11/04/2026 | Bruno Lauterjung | Digital Health News

https://saudedigitalnews.com.br/04/11/2026/oracle-aposta-em-inteligencia-artificial-para-reduzir-barreiras-no-atendimento-e-na-pesquisa-medica/ 

Artificial intelligence can transform the way hospitals, laboratories, and healthcare professionals share information, monitor patients, and develop treatments. That was the main message from Larry Ellison, founder and CTO of Oracle, during Oracle AI World 2026, held last week in Las Vegas, United States. The executive presented a new generation of applications for the healthcare sector, designed to integrate clinical and administrative processes with AI capabilities.

Under the theme “The New Oracle Health Application Suite and the Age of AI,” Ellison outlined the company’s strategy to expand the reach of Oracle Health. The goal is to build a platform capable of connecting hospitals, clinics, laboratories, diagnostic imaging centers, emergency services, and home care, thereby reducing the fragmentation of the systems used by these institutions.

According to the executive, Oracle chose healthcare as the starting point for developing industry-specific applications based on artificial intelligence because it considers this one of the most complex markets in the world. In addition to the diversity of medical specialties, the sector must keep pace with scientific advancements and meet regulatory requirements that vary from country to country.

One of the key proposed changes involves how professionals interact with hospital systems. Instead of navigating through different screens to locate test results, review medical records, or enter information, doctors will be able to use natural language commands to access data and perform specific tasks.

Ellison illustrated the difficulty of current systems by recounting a personal experience in which hospital staff had trouble locating his son’s imaging tests. In the executive’s view, artificial intelligence should allow information to be found directly based on user requests, without the need to understand the software’s structure.

Oracle also aims to simplify the adoption of these new applications. According to Ellison, the modules were developed to run in the cloud and connect to existing hospital systems, including electronic health record platforms from other vendors. The goal is to allow institutions to add specific functionalities without having to replace their entire technological infrastructure.

Among the modules presented are solutions focused on oncology, radiology, emergency medicine, patient monitoring, elder care, and clinical research.

AI Can Expand Access to Clinical Trials in Oncology

Cancer treatment received special attention during the presentation. Ellison stated that artificial intelligence is already contributing to drug development and advocated for expanding patient access to clinical trials.

Currently, according to the executive, many of these studies are concentrated in research hospitals and specialized centers, which makes it difficult for people living far from these institutions to participate.

Oracle’s proposal is to integrate clinical research capabilities into the systems used by hospitals and other healthcare organizations. In this way, institutions that do not traditionally participate in large research networks could incorporate tools to support the identification and follow-up of patients eligible for studies.

Ellison emphasized that this approach could also increase participant diversity, preventing research from being concentrated in a small number of medical centers and geographic regions.

Oncology also holds personal significance for the executive. During the presentation, he shared that he lost his mother to cancer while studying at the University of Illinois. He mentioned this experience when explaining why healthcare has become a priority in his work in technology.

In addition to clinical trials, Ellison discussed the potential of AI to support earlier diagnoses. Among the examples discussed were metagenomic tests for identifying infections and analyses of circulating tumor DNA, which can aid in the detection of certain cancers.

Integration of Medical Records and Remote Monitoring

Another highlight was the proposal to expand interoperability among healthcare institutions. Ellison presented the evolution of Oracle’s patient portal, designed to consolidate clinical information from different hospitals and electronic health record providers.

The initiative initially focuses on the United States and aims to allow patients and authorized professionals to access a more comprehensive medical history, regardless of the institution where the data was recorded.

The platform also includes remote patient monitoring. The proposal involves integrating data from wearable devices and other monitoring equipment with the healthcare professionals responsible for patient care.

Ellison used the example of a person undergoing chemotherapy who develops a fever during the night. With remote monitoring, the medical team could receive information about the patient’s condition and assess the need for intervention, avoiding unnecessary trips or readmissions when they are not clinically necessary.

The connection between ambulances and emergency departments is also part of the strategy. The goal is to enable information about the patient’s condition to be shared during transport, helping the hospital staff prepare before the patient’s arrival.

On the administrative side, Oracle presented features designed to automate prior authorizations for procedures and medications. The proposal is to use clinical information and coverage rules to reduce the back-and-forth of requests between healthcare providers and health insurers.

Security and Integration with Other Technologies
The protection of clinical data was also among the topics discussed. Ellison highlighted biometric authentication mechanisms—including facial, voice, and fingerprint recognition—as part of the strategy to control access to patient information.

According to the executive, the systems must recognize each professional’s permissions and restrict access to data unrelated to their duties.

Oracle also intends to keep the platform open to integration with technologies from other vendors. During the keynote, Ellison cited companies such as NVIDIA, Siemens, GE, and Philips, as well as the use of interoperability standards to connect different systems.

Among the examples presented was the use of artificial intelligence models to support the analysis of imaging exams, including the identification of possible lung lesions in CT scans.

Another possibility discussed was the use of aggregated and anonymized clinical data to support public health decisions. Ellison argued that up-to-date information on patient care, diseases, and hospital capacity could improve the response of public health authorities in public health emergencies.

According to the presented timeline, the first modules of the new Oracle Health suite would begin rolling out in November 2026, with access gradually expanding to institutions participating in the initial phase by early 2027.

With this initiative, Oracle aims to position artificial intelligence as a central element of hospital operations, rather than merely as a complementary tool. The challenge will be to demonstrate, in practice, the ability to integrate existing systems, meet privacy requirements, and translate the presented features into measurable benefits for institutions, professionals, and patients.